US security firm warns: fake drugs "next 9/11"

11 February 2008

A US security consulting firm has warned that the worldwide epidemic of counterfeit pharmaceuticals could be the "world's next 9/11," a reference to the terrorist attacks on September 11, 2001 in New York City and Washington DC. The Global Piracy & Counterfeiting Consultants is part of the Americas Watchdog group.

In a statement, the group said: "the USA, Europe, Japan or Australia are going to get hit sooner or later, with shipments of counterfeit pharmaceutical intentionally or unintentionally designed to kill people." The GP-CC has issued a simple piece of advice to would-be Internet drug purchasers: "consumers should not purchase drugs, pharmaceuticals, medicine of any type on the Internet, unless they are 100% certain it is real."

The problem is that there are several reasons for patients to go on-line to find drugs, the security consultant argues. These include: the belief that on-line drugs are cheaper; unwillingness to approach a physician to obtain a prescription (especially in the case of erectile dysfunction, a significant market for counterfeiters); patients who have been refused a prescription by their physician; and uninsured or low-income patients for whom the cost of a physician's consultation is prohibitive.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight